Versigent (NYSE:VGNT) Stock Rating Upgraded by Argus

Versigent (NYSE:VGNT) was upgraded by Argus to a “strong-buy” rating in a research note issued to investors on Tuesday,Zacks.com reports.

Other equities research analysts also recently issued reports about the company. The Goldman Sachs Group initiated coverage on Versigent in a research note on Monday. They set a “buy” rating and a $48.00 price target for the company. BNP Paribas Exane began coverage on shares of Versigent in a research note on Tuesday, April 28th. They issued an “outperform” rating and a $41.00 price objective on the stock. Oppenheimer set a $50.00 price objective on shares of Versigent in a report on Tuesday. Wolfe Research initiated coverage on shares of Versigent in a research report on Thursday, April 30th. They set an “outperform” rating and a $53.00 target price for the company. Finally, Wells Fargo & Company upped their target price on shares of Versigent from $42.00 to $48.00 and gave the company an “overweight” rating in a report on Thursday, June 25th. Three equities research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, Versigent currently has an average rating of “Buy” and an average price target of $49.67.

Versigent Price Performance

Versigent stock opened at $41.18 on Tuesday. Versigent has a one year low of $26.34 and a one year high of $50.88. The firm’s fifty day moving average price is $43.37.